Initial Public Offerings
Agencia Comercial Spirits Completes Full Over-Allotment Exercise, Raises $8.05 Million in IPO
Taiwan-based premium whisky importer Agencia Comercial Spirits has successfully completed its initial public offering with underwriters exercising the full over-allotment option, raising total gross proceeds of $8.05 million to fund expansion initiatives in the competitive spirits market.
Coca-Cola Considers $1 Billion Indian Bottling IPO to Strengthen Local Partnerships
Coca-Cola is exploring a $1 billion IPO for its Indian bottling subsidiary HCCB, marking a strategic shift toward asset-light operations and deeper local partnerships in one of its fastest-growing markets.
GigCapital8 Corp. Closes $253 Million IPO, Targets High-Tech Business Combination
GigCapital8 Corp. has successfully closed its $253 million initial public offering, positioning the special purpose acquisition company to pursue strategic mergers in aerospace, defense, cybersecurity, and artificial intelligence sectors over the next two years.
Neptune Flood Targets $2.8 Billion Valuation in IPO with T. Rowe Price Backing
Neptune Flood's upcoming IPO, backed by major investors like T. Rowe Price, signals growing confidence in the private flood insurance market and could reshape competition in the property insurance sector.
Glidelogic Corp. Launches AI-Powered RWA IPO Solution to Accelerate Capital Raising and Enhance Market Liquidity
Glidelogic Corp. has introduced an AI-driven compliance platform that significantly reduces IPO timelines and costs while providing dual liquidity options through regulated U.S. and international markets.
Gemini Files for IPO with Plans to List on Nasdaq Under Ticker 'GEMI'
Cryptocurrency exchange Gemini has filed for an initial public offering of up to 16.7 million shares, marking a significant milestone for the crypto industry's maturation and mainstream financial market integration.
D. Boral ARC Acquisition I Corp. Raises $250 Million in IPO for Future Business Combinations
D. Boral ARC Acquisition I Corp. successfully closes its $250 million initial public offering, setting the stage for strategic business combinations in sectors like technology, healthcare, and logistics.
BitBridge Capital Strategies Merges and Goes Public, Pioneering Bitcoin Treasury and Lending Innovations
BitBridge Capital Strategies' merger and public listing marks a significant advancement in Bitcoin treasury and lending, offering innovative products and a mainstream branding campaign to promote Bitcoin adoption.
Unbuzzd Wellness Launches $5 Million Regulation D Offering to Fuel Growth and IPO Ambitions
Unbuzzd Wellness Inc., a portfolio company of Quantum BioPharma Ltd., initiates a $5 million Regulation D offering to support expansion and prepare for a potential IPO, leveraging partnerships with MZ Digital and Dealmaker for a campaign open to traditional and cryptocurrency investments.
Firefly Aerospace Initiates Roadshow for Proposed IPO
Firefly Aerospace announces its roadshow for a proposed initial public offering, marking a significant step in its growth and expansion in the space and defense technology sector.
Quantum BioPharma Ltd. Supports Unbuzzd's $5 Million Fundraising Effort
Quantum BioPharma Ltd. backs Unbuzzd Wellness Inc. in a $5 million Regulation D offering, aiming to expand the reach of its hangover-reducing beverage and paving the way for a future IPO.
Quantum BioPharma Ltd. Clarifies Misinformation Regarding Name Change and RTO
Quantum BioPharma Ltd. (NASDAQ: QNTM) has officially denied rumors of a name change and reverse takeover involving Unbuzzd Wellness Inc., clarifying its financial and operational relationship with the company amidst preparations for Unbuzzd's potential IPO.
Unbuzzd Wellness Prepares for Potential IPO with New Auditor Appointment
Quantum BioPharma's portfolio company Unbuzzd Wellness Inc. has appointed MNP LLP as its new auditor and completed a name change, signaling strategic preparations for a potential public listing and capital raising efforts.
Diplomatic Trade Acquires Major Stake in Turkish Pharmaceutical Company, Targets $300M IPO
Diplomatic Trade Ltd and its investment arm have secured a 49% equity position in a Turkish pharmaceutical company, with plans to launch a bio-manufacturing facility in the UAE and pursue a potential $300 million IPO in late 2025.